首页|期刊导航|实用临床医药杂志|石斛治疗糖尿病脑内微小病变的临床研究及药效学验证

石斛治疗糖尿病脑内微小病变的临床研究及药效学验证OA

Clinical study and pharmacodynamic validation of Dendrobium in the treatment of cerebral microlesions in diabetes

中文摘要英文摘要

目的 通过糖尿病脑内微小病变患者的临床研究和模型大鼠的药效学验证,评价中药石斛对糖尿病脑内微小病变的疗效,并初步探讨其作用机制.方法 临床研究共纳入糖尿病脑内微小病变患者121例,其中研究组62例,对照组59例.2组均给予阿司匹林肠溶片进行基础治疗;研究组在基础治疗基础上给予石斛颗粒,对照组在基础治疗基础上给予石斛颗粒安慰剂.比较2组治疗前后的临床有效率以及脂代谢水平、糖代谢水平和炎症因子水平.动物实验采用糖尿病脑内微小病变大鼠模型,将40只Wistar大鼠随机分为正常对照组、高糖损伤组、阿司匹林损伤组和石斛多糖组.通过生化检测、脑组织病理学检测及头颅MRI检测评估糖尿病大鼠脑内微小病变的变化.结果 临床研究中,治疗后研究组临床有效率为77.4%,高于对照组的57.6%,差异有统计学意义(P<0.05);治疗后,研究组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和载脂蛋白 B下降水平以及糖化血红蛋白(Hb1Ac)、空腹血糖(FBG)和餐后2 h血糖(2 h PG)下降水平高于对照组,差异有统计学意义(P<0.05);研究组超氧化物歧化酶(SOD)升高优于对照组,白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)下降水平优于对照组,差异有统计学意义(P<0.05).动物实验中,与高糖损伤组相比,阿司匹林损伤组和石斛多糖组的核因子κB(NF-κB)含量降低,差异有统计学意义(P<0.05);高糖损伤组血管内皮生长因子(VEGF)高于正常对照组,差异有统计学意义(P<0.05).苏木精-伊红(HE)染色结果显示,与正常对照组比较,高糖损伤组脑组织神经元数目明显减少,神经胶质细胞显著增生;阿司匹林损伤组神经元减少、神经胶质细胞增生,石斛多糖组神经元稍微减少、神经胶质细胞稍微增生.头颅MRI检测结果显示,石斛多糖可显著减少糖尿病大鼠脑内微小病变个数(P<0.05).结论 石斛能有效减少脑内微小病变数量,调节脑内微小病变患者血糖和血脂水平.

Objective To evaluate the therapeutic efficacy of the traditional Chinese medicine Dendrobium for diabetic cerebral microangiopathy and preliminarily explore its underlying mechanisms through clinical studies in patients with diabetic cerebral microangiopathy and pharmacodynamic validation in rat model.Methods A total of 121 patients with diabetic cerebral microangiopathy were enrolled in the clinical study,including 62 in study group and 59 in control group.Both groups received as-pirin enteric-coated tablets as the baseline treatment;the study group additionally received Dendrobi-um granules,while the control group received a placebo of Dendrobium granules.Clinical efficacy rates,lipid metabolism profiles,glucose metabolism parameters and inflammatory cytokine levels were compared between the two groups before and after treatment.For the animal experiment,a rat model of diabetic cerebral microangiopathy was established,and 40 Wistar rats were randomly divid-ed into normal control group,hyperglycemic injury group,aspirin injury group and Dendrobium pol-ysaccharide group.Changes in cerebral microangiopathy in diabetic rats were assessed using bio-chemical assays,cerebral histopathological examinations,and cranial MRI.Results In the clinical study,the post-treatment clinical efficacy rate in the study group was 77.4%,which was signifi-cantly higher than 57.6%in the control group(P<0.05).After treatment,the study group exhibi-ted significantly greater reductions in total cholesterol(TC),triglycerides(TG),low-density lipo-protein cholesterol(LDL-C)and apolipoprotein B,as well as reductions in glycated hemoglobin(HbA1c),fasting blood glucose(FBG)and 2-hour postprandial blood glucose(2 h PG),com-pared with the control group(P<0.05).The study group also showed a significantly greater in-crease in superoxide dismutase(SOD)level and greater reductions in interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)levels compared with the control group(P<0.05).In the animal experiment,compared with the hyperglycemic injury group,the aspirin injury and Dendrobium poly-saccharide groups exhibited significantly lower nuclear factor-kappa B(NF-κB)levels(P<0.05).The hyperglycemic injury group had significantly higher vascular endothelial growth factor(VEGF)levels than the normal control group(P<0.05).Hematoxylin-eosin(HE)staining revealed a marked reduction in neuronal count and significant glial cell proliferation in the hyperglycemic injury group compared with the normal control group.The aspirin injury group showed neuronal loss and glial pro-liferation,while the Dendrobium polysaccharide group exhibited only mild neuronal reduction and glial proliferation.Cranial MRI demonstrated that Dendrobium polysaccharide significantly reduced the number of cerebral microangiopathic lesions in diabetic rats(P<0.05).Conclusion Dendrobium effectively reduces the number of cerebral microangiopathic lesions and regulates blood glucose and lipid levels in patients with diabetic cerebral microangiopathy.

陆颖;李全耀;闫振国;王长德;陈卉;游毅;吴春岚;刘笑迎

上海中医药大学附属上海市中西医结合医院脑病科,上海,200082||上海市静安区彭浦新村街道社区卫生服务中心中医科,上海,200443同济大学附属上海市第四人民医院中医科,上海,200434上海中医药大学附属宝山中西医结合医院神经内科,上海,201900上海中医药大学附属上海市中西医结合医院脑病科,上海,200082上海中医药大学附属上海市中西医结合医院脑病科,上海,200082上海中医药大学附属上海市中西医结合医院脑病科,上海,200082上海中医药大学附属上海市中西医结合医院脑病科,上海,200082上海中医药大学附属上海市中西医结合医院脑病科,上海,200082

医药卫生

中药石斛糖尿病并发症脑小血管病随机对照试验炎症氧化应激治疗结果

traditional Chinese medicineDendrobiumdiabetic complicationscerebral small vessel diseaserandomized controlled trialinflammationoxidative stresstreatment outcomes

《实用临床医药杂志》 2026 (7)

1-8,8

国家中医优势专科建设项目(20240511)虹口区科学技术委员会重大课题(虹卫2301-02)上海市卫生健康委员会医学新技术研究与转化种子计划项目(2024ZZ2067)

10.7619/jcmp.20255916

评论